Back to search

Boston University

The role of SOX2 and OCT4 pluripotency markers in relation to TGF-β3- mediated in epithelial-mesenchymal transition during palatal fusion

Abstract

dc:description.abstract

BACKGROUND AND OBJECTIVE: We aimed to elucidate the relationship between TGF-β3 signaling and the expression of pluripotency markers during EMT in palatal fusion. MATERIALS AND METHODS: Palatal samples were collected from the secondary palate of fetuses from timed-pregnant C57BL mice at the E15 stage before palatal fusion. E15 palatal epithelial cells were isolated using magnetic cell sorting with CD326 microbeads and treated with 1, 3, or 10 ng/ml TGF-β3. To identify the role of TGF-β3, its expression was knocked down, and downstream signaling was measured through Smad2, Smad3, Smad4, Snail, p38, and MMP13. The epithelial cell barrier function was measured by transepithelial electrical resistance (TEER). Next-generation RNA sequencing was performed to confirm the result of qRT-PCR. To further identify the role of each pluripotency marker, we knocked down SOX2 and OCT4, either alone or together, and treated cells with 1 ng/ml TGF-β3. E-cadherin, Fibronectin, SOX2, and OCT4 expression in the epithelial lining were measured by immunofluorescence. RESULTS: There was a significant decrease in E-cadherin and an increase in fibronectin in response to1-3 ng/ml TGF-β3 treatment (p<0.05). TEER analysis demonstrateda significant decrease in resistance with 1 ng/ml TGF-β3 (p<0.05). Snail expression was increased in response to all doses of TGF-β3 (p<0.05). MMP13 was increased with 1 ng/ml TGF-β3 (P<0.05). RNA sequencing confirmed the activation of EMT with 1 ng/ml TGF- β3 and knockdown of TGF-β3. SOX2 and OCT4 signaling decreased from E14.5 to E15.5, and TGF-β3 significantly reduced their expression.TGF-β3 knockdown decreased SOX2 and increased OCT4 (p<0.05). TGF-β3 levels were significantly decreased by knockdown of SOX2, OCT4, SOX2/OCT4, and SOX2/OCT4 in response to1 ng/ml TGF-β3 (p<0.05). The most significant changes in E-cadherin and fibronectin were observed with SOX2/OCT4 knockdown in response to 1 ng/ml TGF-β3. CONCLUSIONS: TGF-β3 at an optimal 1-3 ng/ml concentration, reduced epithelial marker and increased mesenchymal marker expression, suggesting EMT in vitro. TGF-β3 downregulation of SOX2 and OCT4 may be required for successful palatal fusion.

Degree

thesis:*
Name thesis:degree_name
Doctor of Science in Dentistry
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Orthodontics and Dentofacial Orthopedics
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mahatumarat, Natcha
Advisors dc:contributor.advisor
  • Kantarci, Alpdogan
  • Will, Leslie A.
ORCID dc:identifier.orcid

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/50603

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mahatumarat, Natcha. The role of SOX2 and OCT4 pluripotency markers in relation to TGF-β3- mediated in epithelial-mesenchymal transition during palatal fusion. doctoral thesis, Boston University, 2025. https://hdl.handle.net/2144/50603